NCT05547815View on ClinicalTrials.gov

Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine

PHASE4CompletedINTERVENTIONAL

Enrollment

149

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

December 17, 2020

Study Completion Date

November 8, 2021

Conditions

RabiesAntibody

Interventions

BIOLOGICAL

5 doses program

Inoculate 5 doses of rabies vaccine, and collect blood at fixed time points to detect neutralizing antibody

Trial Locations (1)

130000

Changchun Zhuoyi Biological Co., Ltd, Changchun

All Listed Sponsors

lead

Changchun Zhuoyi Biological Co., Ltd

OTHER

NCT05547815 - Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine | Biotech Hunter | Biotech Hunter